Literature DB >> 24474645

Segmental anterior cervical corpectomy and fusion with preservation of middle vertebrae in the surgical management of 4-level cervical spondylotic myelopathy.

Zhonghai Li1, Zhenggang Guo, Shuxun Hou, Yantao Zhao, Hongbin Zhong, Shunzhi Yu, Tiesheng Hou.   

Abstract

PURPOSE: To compare perioperative parameters, clinical outcomes, radiographic parameters, and complication rates of segmental anterior cervical corpectomy and fusion (sACCF) plus preservation of middle vertebrae with those of cervical laminectomy plus fusion (CLF) in 67 patients with 4-level cervical spondylotic myelopathy (CSM).
METHODS: Between July 2006 and May 2012, 67 consecutive patients [42 males and 25 females; mean age 57.8 years (range 34-77 years)] with 4-level CSM who underwent surgery and were followed for more than 1 year were enrolled in this study and divided into sACCF and CLF groups. The study compared perioperative parameters; surgery-related and instrumentation- and graft-related complication rates; clinical parameters; patient satisfaction; and radiologic parameters.
RESULTS: Significant improvements were seen from preoperative to postoperative in both groups for all three measures of clinical outcome; between-group comparison revealed no significant difference for two of the three measures and significantly better scores for the CLF group in the third. Satisfaction was rated as excellent or good by 79.5 % of the sACCF group and 71.4 % of the CLF group, which was not a significant difference. Mean postoperative cervical lordosis was significantly greater in the sACCF group than in the CLF group. Blood loss and operative time were significantly greater in the CLF group than in the sACCF group and complication rate significantly lower for the sACCF group.
CONCLUSIONS: sACCF with preservation of middle vertebrae is a safe, reliable, and effective alternative procedure for the treatment of 4-level CSM.

Entities:  

Mesh:

Year:  2014        PMID: 24474645     DOI: 10.1007/s00586-014-3208-z

Source DB:  PubMed          Journal:  Eur Spine J        ISSN: 0940-6719            Impact factor:   3.134


  43 in total

1.  Preservation of muscles attached to the C2 and C7 spinous processes rather than subaxial deep extensors reduces adverse effects after cervical laminoplasty.

Authors:  Hironobu Sakaura; Noboru Hosono; Yoshihiro Mukai; Takahito Fujimori; Motoki Iwasaki; Hideki Yoshikawa
Journal:  Spine (Phila Pa 1976)       Date:  2010-07-15       Impact factor: 3.468

2.  A comparison of anterior cervical fusion, cervical laminectomy, and cervical laminoplasty for the surgical management of multiple level spondylotic radiculopathy.

Authors:  H N Herkowitz
Journal:  Spine (Phila Pa 1976)       Date:  1988-07       Impact factor: 3.468

3.  Validity and reliability of the Short Form-36 in cervical spondylotic myelopathy.

Authors:  Joseph T King; Mark S Roberts
Journal:  J Neurosurg       Date:  2002-09       Impact factor: 5.115

4.  Incidence and outcome of kyphotic deformity following laminectomy for cervical spondylotic myelopathy.

Authors:  G J Kaptain; N E Simmons; R E Replogle; L Pobereskin
Journal:  J Neurosurg       Date:  2000-10       Impact factor: 5.115

5.  Treatment options and results in cervical myelopathy.

Authors:  H M Mehdorn; M J Fritsch; R U Stiller
Journal:  Acta Neurochir Suppl       Date:  2005

6.  Is dysphonia permanent or temporary after anterior cervical approach?

Authors:  Serdar Kahraman; Sait Sirin; Ersin Erdogan; Cem Atabey; Mehmet Daneyemez; Engin Gonul
Journal:  Eur Spine J       Date:  2007-09-08       Impact factor: 3.134

7.  Surgical management of dissociated motor loss following complex cervical spine reconstruction.

Authors:  John E O'Toole; Ty J Olson; Michael G Kaiser
Journal:  Spine (Phila Pa 1976)       Date:  2004-02-01       Impact factor: 3.468

8.  Comparison of 3 reconstructive techniques in the surgical management of multilevel cervical spondylotic myelopathy.

Authors:  Yang Liu; Yang Hou; Lili Yang; Huajiang Chen; Xinwei Wang; Xiaodong Wu; Rui Gao; Ce Wang; Wen Yuan
Journal:  Spine (Phila Pa 1976)       Date:  2012-11-01       Impact factor: 3.468

9.  The Neck Disability Index: a study of reliability and validity.

Authors:  H Vernon; S Mior
Journal:  J Manipulative Physiol Ther       Date:  1991-09       Impact factor: 1.437

10.  Cervical laminoplasty for multilevel cervical myelopathy.

Authors:  Murali Krishna Sayana; Hassan Jamil; Ashley Poynton
Journal:  Adv Orthop       Date:  2011-10-02
View more
  5 in total

1.  A comparison of a new zero-profile, stand-alone Fidji cervical cage and anterior cervical plate for single and multilevel ACDF: a minimum 2-year follow-up study.

Authors:  Zhonghai Li; Yantao Zhao; Jiaguang Tang; Dongfeng Ren; Jidong Guo; Huadong Wang; Li Li; Shuxun Hou
Journal:  Eur Spine J       Date:  2016-08-23       Impact factor: 3.134

2.  One stage laminoplasty and posterior herniotomy for the treatment of myelopathy caused by cervical stenosis with cervical disc herniation.

Authors:  Bin Yue; Bohua Chen; Xue-Xiao Ma; Yong-Ming Xi; Hong-Fei Xiang; You-Gu Hu; Guoqing Zhang
Journal:  Int J Clin Exp Med       Date:  2015-06-15

3.  Prevalence of complications after surgery in treatment for cervical compressive myelopathy: A meta-analysis for last decade.

Authors:  Tao Wang; Xiao-Ming Tian; Si-Kai Liu; Hui Wang; Ying-Ze Zhang; Wen-Yuan Ding
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

4.  A biomechanical analysis of four anterior cervical techniques to treating multilevel cervical spondylotic myelopathy: a finite element study.

Authors:  Zhonghai Li; Hui Liu; Ming Yang; Wentao Zhang
Journal:  BMC Musculoskelet Disord       Date:  2021-03-15       Impact factor: 2.362

5.  Anterior cervical corpectomy and fusion with stand-alone cages in patients with multilevel degenerative cervical spine disease is safe.

Authors:  Mohamed H Tohamy; Georg Osterhoff; Ahmed Shawky Abdelgawaad; Ali Ezzati; Christoph-E Heyde
Journal:  BMC Musculoskelet Disord       Date:  2022-01-03       Impact factor: 2.362

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.